Sofpromed is a full service Clinical Research Organization (CRO) specialized in the global management of phase I-IV clinical trials worldwide for biotechnology and pharmaceutical companies across all therapeutic areas.
We manage clinical trials globally in the United States, United Kingdom, Europe, Asia-Pacific, Middle East, North Africa, and Latin America.
The therapeutic expertise of our staff includes oncology, cardiovascular, metabolic, central nervous system, dermatology, infectious and respiratory diseases, among other areas.
We provide regulatory, clinical operations, data management, biostatistics, pharmacovigilance, bioanalysis, and medical writing services to streamline the execution of clinical trials and the development of innovative treatments.
In addition, we facilitate formulation development, analytical testing, drug manufacturing, labeling, packaging, storage, and distribution solutions for clinical trial sponsors around the world.
Sofpromed was founded in 2012 in Spain, by Patricio Ledesma, current Chief Executive Officer.